A Study to Assess the Relative Bioavailability of Tablet Formulations of GSK2248761 in Healthy Adult Subjects. SGN114435

Clinical trial NCT01209117 · COMPLETED

Trial details

NCT number: NCT01209117
Sponsor: ViiV Healthcare
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Infections, Human Immunodeficiency Virus and Herpesviridae Infection, Human Immunodeficiency Virus

Start date: 2010-09-01
Primary completion: 2011-01-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.